Fundraising Fox

Albert Invent

5 employees · 8 known investors

albertinvent.com ↗

Albert provides an operating system for chemists that combines structured data management with AI trained on molecular structures and individual company chemistry datasets. The platform centralizes lab notebooks, experiments, and projects while enabling AI-driven predictions for formulation optimization and discovery acceleration in materials and chemical R&D.

Also known as Albert · Albert Invent Corp

AI & Machine LearningDeep TechEnterprise Software

Founders & leadership

ZK
Zach KisnerinCo-Founder, Chief Work Officer
KKKen Kisner
Ken KisnerinStrategy, Chairman, Co-Founder
NTNick Talken
Nick TalkeninCo-Founder & CEO
NVNeelesh Vaikhary
Neelesh VaikharyinCo-founder & CTO2022–2025
ZK
Zack KisnerFounder

Investors · 8

Also in the syndicate · 1

J.P. Morgan Private Capital's Growth Equity Partnerslead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Company profile

researched Aug 2026

Albert Invent, founded in 2022 and based in Oakland, California, develops an end-to-end research and development platform for the chemical and materials science industries. The product combines structured data capture with AI models intended to accelerate formulation and materials discovery. Core platform components described by the company and its investors include an inventory module with a pre-loaded library of more than 50,000 commercially available chemicals, an Excel-alternative worksheet for designing formulations, experiment tracking with structured data capture, electronic lab notebooks with block-based editing and chemical drawing, project management, and regulatory automation that generates safety data sheets and labels using built-in rules covering 400,000 chemical substances. An AI layer, marketed as Albert Insights and later as Albert Breakthrough and Ask Albert, provides recommendations, property predictions, experiment suggestions, and formulation optimization.

The company positions itself against siloed and legacy R&D record-keeping in the chemicals sector, and states it has developed methods for digitizing and unifying research records at scale, from paper notebooks to fragmented legacy software and desktop files. Its AI is described as built on a foundation of 15 million molecular structures and algorithms trained on data from more than 50,000 raw materials, then further trained on each customer's proprietary experimental data. Beyond software, Albert offers change management services including readiness assessments, training, and ongoing support.

Founding story

Albert traces its origins to Molecule, a 3D-printing materials company launched by chemical engineer Nick Talken with Ken Kisner. To organize and speed lab work, the pair hired data experts to build software designed specifically for scientists. Molecule was later acquired by adhesives maker Henkel, which further developed the software and then spun it off as the separate entity Albert Invent. Index Ventures describes Talken and Kisner as former chemicals entrepreneurs in the 3D materials space who created Albert to connect processes, data, and insights into a single end-to-end source of truth for chemicals R&D.

Business model

Albert sells a software platform to chemical, materials science, and personal care companies, deployed to scientists across customer labs, and complements it with implementation and change-management services such as readiness assessments and training. Customer data is described as isolated, encrypted, and used to train customer-specific models. The company has also built customer-facing digital portals, such as Nouryon's BeautyCreations formulation portal, which it frames as a new revenue channel for customers.

Sources do not disclose pricing or contract structure; the platform is offered as a cloud-based R&D software platform to enterprise customers, with demos requested through the company website.

Traction

Index Ventures reported thousands of users in more than 30 countries in June 2023. Named customers across sources include Henkel (described as one of Albert's largest customers), Chemours, Diversey, Keystone Industries, Nouryon, Solenis, 3D Systems, Applied Molecules, and Kenvue. The company website cites 3,000 scientists across 142 labs achieving 2x speed to market, development time reduced from three months to two days, and 1,800 formulas downloaded from an AI discovery portal. C&EN reported over a dozen partnerships as of October 2025.

Latest developments

In October 2025, C&EN reported a partnership under which chemists across Kenvue gain access to Albert's AI platform, configured so models can learn from Kenvue's proprietary data, with plans to roll it out to all Kenvue scientists creating formulations in the lab. The article also stated Albert had raised over $50 million to date and had over a dozen partnerships. Earlier, Albert announced a growth round led by J.P. Morgan Growth Equity Partners with Coatue and TCV, taking total funding past $45 million, to be used for global team building and scaling to meet customer demand.

▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

Index Ventures frames Albert as addressing the roughly $5 trillion global chemicals industry, much of which still operates on paper or siloed legacy on-premises software. C&EN positions Albert within a rising market for AI-enhanced chemistry R&D services, noting the company had over a dozen partnerships as of October 2025.

The company emphasizes models trained on each customer's own chemistry rather than generic predictions, a chemistry-native unified data model, founder and team backgrounds as practicing chemists with experience at Dow, BASF, PPG, and Henkel, and demonstrated capability to structure and integrate large volumes of historical experimental data from paper and legacy systems.

Technology

A unified data model that centralizes projects, materials, and experiments with molecular-level structured capture. AI models are built on a foundation of 15 million molecular structures and trained on data from more than 50,000 raw materials, then fine-tuned on customer experimental data to predict properties, optimize formulations, and design experiments. Additional capabilities include molecular-design aids, experiment simulation, electronic lab notebooks, chemical drawing, regulatory rules covering 400,000 chemical substances for automated safety data sheets and labels, role-based access control, encryption, and integrations with existing customer systems.

Go-to-market

Direct enterprise sales with demo requests via the website, supported by customer-success and change-management teams; the company has cited large reference customers and case studies, and markets in English and Japanese. Funding has been directed at scaling data science, engineering, customer success, and go-to-market functions and at hiring in Germany, Japan, India, and the US.

Chemical, materials science, and personal care companies of all sizes, and the R&D chemists, formulators, and lab scientists within them.

Geography

Headquartered at 492 9th St, Suite 260, Oakland, California, United States, with users in 30+ countries and stated hiring in Germany, Japan, India, and the US. The website is offered in English and Japanese.

History

The company was founded in 2022. In June 2023 it announced a $7.5 million seed round led by Index Ventures with participation from Homebrew, F-Prime Capital, and angel investors. It subsequently announced a $22 million Series A and launched Albert Breakthrough, an interface for chemist-AI collaboration that generates experimental suggestions, predicts molecular properties, and optimizes formulations. A later growth round led by J.P. Morgan Private Capital's Growth Equity Partners, with Coatue and TCV participating, brought total funding above $45 million; by October 2025 C&EN reported the company had raised over $50 million. In October 2025 Albert announced a partnership with consumer health company Kenvue.

Risks & controversies

The website carries a disclaimer that cited customer results reflect individual user experiences and are not guarantees of similar outcomes. Several headline performance metrics originate from the company's own marketing materials rather than independent verification. No controversies are reported in the available sources.

Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Chemical substances covered by regulatory rulesJan 2026400,000 substances
Countries with usersJun 202330
Customer labs cited caseJan 2026142 labs
Customer scientists on platform cited caseJan 20263,000 scientists
Development time reduction cited caseJan 2026Development time reduced from 3 months to 2 days using AI
Formulas downloaded from ai discovery portalJan 20261,800 formulas
Founded yearOct 20252,022 year
Molecular structures in foundation modelJan 202615,000,000 molecular structures
PartnershipsOct 202512 partnerships
Pre loaded chemical library sizeJun 202350,000 commercially available chemicals
Raw materials in training dataOct 202550,000 raw materials
Total funding raisedOct 2025$50M

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Competitors · 4

by search overlap

Companies competing with Albert Invent for the same Google search keywords, organic and paid, via search-intersection analysis.

Timeline · 7

launches, deals, and filings
Oct 2025
Partnership with Kenvue

Kenvue chemists gain access to Albert's AI platform, configured so models can learn from Kenvue's proprietary data, with plans to roll out to all Kenvue formulation scientists.

source ↗

Jan 2025
Growth round led by J.P. Morgan Growth Equity Partners brings total funding above $45M

Growth funding round led by J.P. Morgan Private Capital's Growth Equity Partners with participation from Coatue and TCV; proceeds earmarked for global hiring in Germany, Japan, India and the US.

source ↗

Jan 2025
BeautyCreations digital portal built for Nouryon

Albert helped specialty chemical maker Nouryon launch BeautyCreations, a portal where personal care formulators describe a product in natural language and receive formulation options from Nouryon's formula database.

source ↗

Jan 2024
$22 million Series A announced

Pulse 2.0 reported that in the prior year Albert Invent announced a $22 million Series A round alongside the launch of Albert Breakthrough.

$22M source ↗

Jan 2024
Launch of Albert Breakthrough

An interface for chemists and AI to collaborate, generating experimental suggestions, predicting molecular properties, and optimizing formulations.

source ↗

Jun 2023
Albert raises $7.5M seed round led by Index Ventures

Seed funding of $7.5 million led by Index Ventures with participation from Homebrew, F-Prime Capital and angel investors, to scale data science, engineering, customer success and go-to-market teams.

$7.5M source ↗

Jan 2022
Spun off from Henkel as an independent company

Albert's software originated at 3D-printing materials company Molecule, which Henkel acquired; Henkel further developed the software and spun Albert Invent off as a separate entity.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

▸Research sources · 7

primary sources listed

7 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Albert Invent do?
Albert Invent builds an AI-enabled R&D operating system for chemists and materials scientists.
Who founded Albert Invent?
Albert Invent was founded by Zach Kisner, Ken Kisner, Nick Talken, Neelesh Vaikhary.
Who are Albert Invent's investors?
Albert Invent's investors include CapitalG, Coatue Management, Coral Capital, F-Prime Capital, Homebrew, Index Ventures, General Atlantic.